skip to main content
Download PDF Email print vcard Share

Overview

Deirdre has 30 years of experience in strategic biotechnology and life sciences patent prosecution counseling.

She is dedicated to guiding clients through the identification, protection, and management of intellectual property (IP) rights to achieve their business goals.

Deirdre prepares and prosecutes U.S. and foreign patent applications for her clients, and works to maximize her clients’ patent scope and duration, throughout the U.S., Europe, and Asia. Deirdre also drafts legal opinions regarding infringement, validity, and freedom-to-operate and conducts IP due diligence studies and audits.

Deirdre’s patent practice is focused in the field of biotechnology with an emphasis in the areas of biologics, including antibody-based therapeutics, biomarkers, pharmaceuticals, gene editing, medical devices, drug discovery/development, precision medicine, immuno-oncology, immunotherapy, bioinformatics, assays and protein-based sensors.

Her practice includes experience in the following areas:

  • Immunology and antibody technologies,
  • RNA (including siRNA, antisense, and microRNA)
  • Vaccine development and optimization
  • Gene therapy, gene editing (including CRISPR) and gene activation
  • Chimeric antigen receptor technology, including CAR-T and CAR-NK cell therapies
  • Genetic diagnostics
  • Pharmaceuticals and drug development (drug discovery and delivery)
  • Proteins and peptide therapeutics
  • Neurobiology
  • Pluripotent stem cell isolation and differentiation
  • Nanotechnology, including nanoparticles and nanoparticle delivery
  • Therapeutics and diagnostics for cancer, neurodegenerative and metabolic disorders
  • Nucleic acid sequencing and detection/labeling technologies, including immunofluorescence
  • COVID-19 and related technologies

Patent prosecution is in Deirdre’s blood.  In fact, her great grandfather, Graham Cravens, is the inventor of multiple patents, including a patent for “Apparatus for raising superstructures and ballasting railway road-beds.”  She is committed to growing her international practice, has traveled to China multiple times, and has spoken before the Chinese Patent Office, as well as to members of the Chinese life sciences industry and legal community.  Deirdre also has a strong history of serving the needs of universities and innovation centers nationwide and globally.

The success of Deirdre’s practice is fueled by the balance of her strategic biotechnology patent prosecution counseling and her general intellectual property litigation and enforcement experience. Clients benefit from Deirdre’s experience with intellectual property contested matters, including patent oppositions, arbitration proceedings, litigation relating to infringement and validity, and license agreements.

Deirdre has been recognized in The Best Lawyers® in America for Patent Law in Boston since 2016. Since 2022, she has also been individually recognized by IAM Patent 1000 for her patent prosecution expertise. She has been selected to Super Lawyers® since 2021, a distinction recognizing outstanding lawyers who have attained a high degree of peer recognition and professional achievement. Additionally, Deirdre was recognized as a Life Sciences Star for Patent Prosecution by LMG Life Sciences from 2022 through 2025, the final year in which LMG published its rankings.

Deirdre is a Past President of the Boston Intellectual Property Law Association (BIPLA) and is Founder and Co-Chair of the BIPLA Legislative Committee. She currently serves on the Advisory Board for the Northeastern University Chapter of National Academy of Inventors. She is Past Chair for the Venture Forum and was a Board member of SBANE. She was the keynote speaker at "WIPR Influential Women in IP,” and has recently spoken at AUTM and MassBio regional events.

Credentials

Bar Admissions

  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court, District of Massachusetts
  • U.S. Patent and Trademark Office
  • Massachusetts

Education

  • B.A. in Biology and Anthropology, magna cum laude, State University of New York at Albany
  • M.A. in Anthropology, State University of New York at Albany
  • J.D., Boston College Law School

Speaking Engagements

Professional Associations

  • Boston Intellectual Property Law Association (BIPLA)
    • Past President
    • Chair of the Legislative Committee
  • Advisory Board, Northeastern University Chapter of National Academy of Inventors
  • The Venture Forum, Past Chair

Chinese Translated Biography

Deirdre Sanders

教育背景

  • 波士顿学院法学院，法律博士
  • 纽约州立大学奥尔巴尼分校，人类学文学硕士
  • 纽约州立大学奥尔巴尼分校，生物学与人类学文学学士，以极优异成绩毕业

技术领域：生物制剂与免疫疗法、生物技术与生命科学、生物信息学、医疗器械、药物、基因编辑、免疫肿瘤学、疫苗、诊断技术、纳米技术

Deirdre 是 Hamilton Brook Smith Reynolds 律师事务所的股东合伙人。她是一位在生物技术与生命科学领域的专利申请及审查策略咨询方面拥有 30 年经验的律师。她致力于指导客户识别、保护和管理知识产权（IP），以实现其商业目标。

Deirdre 为客户撰写专利申请文件并督导专利申请及审查相关工作，致力于在美国及全球范围内最大限度地扩大客户专利的保护范围并延长保护期限。Deirdre 还起草有关侵权、有效性和自由实施的法律意见书，并开展知识产权尽职调查和审计。

Deirdre 的专利业务专注于生物技术与生命科学领域，尤其侧重于生物制剂与免疫疗法。其业务涉及基于抗体的治疗药物、生物标志物、药物、基因编辑、医疗器械、药物发现/开发、精准医疗、免疫肿瘤学、免疫疗法、生物信息学、检测方法以及基于蛋白质的传感器。

自 2016 年起，Deirdre 因其在波士顿地区专利法律业务领域的成就而入选 The Best Lawyers® in America（美国最佳律师）。自 2022 年起，Deirdre 凭借其在专利申请及审查事务方面的专业能力，以个人身份获得 IAM Patent 1000 的认可。自 2021 年起，她一直入选 Super Lawyers®（超级律师），该评级面向获得同行高度认可并取得卓越专业成就的杰出律师。自 2022 年起，Deirdre 被 LMG Life Sciences 评为专利申请及审查事务领域的顶尖生命科学律师之一。Deirdre 曾任波士顿知识产权法律协会 (BIPLA)会长，并且是 BIPLA 立法委员会的创始人兼联合主席。她目前是美国国家发明家科学院东北大学分会顾问委员会成员。

News & Insights